Alterations in Gait, Strength, and Power After Ruck Marching (SPARTAN)

August 15, 2023 updated by: Riana Pryor, State University of New York at Buffalo
The purpose of this study is to determine change in injury risk and performance variables in males and females after walking unloaded and carrying a load with two different distributions (high-pack placement and mid-pack placement) to identify differences in injury risk

Study Overview

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • New York
      • Buffalo, New York, United States, 14214
        • University at Buffalo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 39 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy, physically active individuals
  • 18-39 years old

Exclusion Criteria:

  • History of musculoskeletal injury within the last six months or still under a physicians care for an injury occurring more than six month prior
  • History of spinal disc injury
  • History of cardiovascular, metabolic, respiratory, neural, or renal disease
  • No previous history or education of completing resistance exercise
  • Hypertensive or tachycardic during the screening visit (SBP > 139 mmHg, DBP > 89 mmHg, heart rate > 100 bpm)
  • Taking medication or supplements with a known side effect of affecting physiologic responses to exercise (e.g., beta blockers, omega-3 fatty acids, statins, aspirin)
  • Any form of tobacco or nicotine use
  • A positive pregnancy test at any point in the study
  • Study physician discretion based on any other medical condition or medication
  • Gastrointestinal disease or previous surgery prohibiting internal body temperature pill use. Subjects who have any contraindication to internal body temperature pill ingestion will be given the option to insert the pill rectally (as a suppository) or use a rectal probe.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Unloaded Walking
Walking on a treadmill without wearing a pack
Walking three miles on a treadmill at a self-selected speed
Experimental: Loaded Walking High
Walking on a treadmill while wearing a 30% body mass load with the weight placed at the high-back
Walking three miles on a treadmill at a self-selected speed while wearing a backpack with weight carried high on the back
Experimental: Loaded Walking Mid
Walking on a treadmill while wearing a 30% body mass load with the weight placed at the mid-back
Walking three miles on a treadmill at a self-selected speed while wearing a backpack with weight carried on the mid-back

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Oxygen Consumption
Time Frame: Upon completion of 3 miles of walking, an average of 45 minutes
Oxygen consumption will be measured using indirect calorimetry
Upon completion of 3 miles of walking, an average of 45 minutes
Increased muscular jerk
Time Frame: Upon completion of 3 miles of walking, an average of 45 minutes
Jerk will be measured using accelerometers placed at the torso and ankle
Upon completion of 3 miles of walking, an average of 45 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Riana Pryor, PhD, University at Buffalo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 21, 2022

Primary Completion (Actual)

July 21, 2023

Study Completion (Actual)

July 21, 2023

Study Registration Dates

First Submitted

March 24, 2022

First Submitted That Met QC Criteria

April 1, 2022

First Posted (Actual)

April 4, 2022

Study Record Updates

Last Update Posted (Actual)

August 16, 2023

Last Update Submitted That Met QC Criteria

August 15, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • STUDY00006175

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

We do not plan to share IPD with other researchers.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fatigue

Clinical Trials on Walking

3
Subscribe